DETAILS, FICTION AND WORMHOLE FOUNDATION

“We proudly support Cadenza’s efforts to dramatically improve the lives of patients suffering from demyelinating illness. Our conviction in Cadenza is multifaceted; CAD-one is an elegant Option to a primary market need, there are strong opportunities for secondary indications inside the future, along with the company has assembled an extraord